首页 > 最新文献

Journal of Medical and Scientific Research最新文献

英文 中文
COVID-19 vaccination and its influence on the disease severity among the COVID patients in a tertiary care hospital – A cross sectional study 一家三级医院的 COVID-19 疫苗接种及其对 COVID 患者疾病严重程度的影响 - 一项横断面研究
Pub Date : 2023-10-02 DOI: 10.17727/jmsr.2023/11-54
Meena Ms, Sangumani J, Brahadeesh M, Natrajan A, John J, Jeyaseelan Djw
Introduction: COVID-19 disease was a global health emergency from March 2020 till May 2023 with no effective drug to date. COVID-19 vaccines with other precautious measures like hand washing, disinfection, social distancing etc. were the only ways to decrease the burden of the disease worldwide. The study aimed to determine the association between COVID-19 vaccination and disease severity among COVID-19 patients admitted to a Government Medical College hospital. Methods: This cross sectional study included 983 COVID-19 patients admitted to a tertiary care hospital from March 2021 to December 2021. Secondary data were collected from the case sheets and vaccination details were collected from the patients over the phone and through COWIN App. Chi-square test and binary logistic regression were done and the p value and odds ratio were estimated. Results: 92.9% of study participants were unvaccinated, 2.7% were fully vaccinated, and 4.3% were partially vaccinated. Among fully vaccinated 11.1% had breathlessness, 0% ICU admission, 3.7% died, 20% had COVID pneumonia findings in CT lung, 9% had low lymphocyte levels which were statistically significantly lower than in partially vaccinated (39.5%, 41.9%, 7%, 18.6%, 59.3%, 65.1%, 76.9% respectively) and unvaccinated (31.1%, 27.7%, 2%, 4.6%, 48.2%, 45.2%, 68.4% respectively). Conclusion: Two doses of vaccines provided significant protection from severe forms of the disease. Partially vaccinated were affected more, which may be due to insufficient immunity gained and their careless attitude post-vaccination with decreased shielding behaviour. The present study shows that partial vaccination is not protective against the progression of COVID-19 disease severity. More focus should be made on full vaccination of the community and educating the public about complete vaccination and emphasis on preventive measures even after vaccination must be made to reduce the burden of COVID-19 in the community. Keywords: COVID-19; COWIN App; vaccination; coronavirus disease
导言:COVID-19 疾病是 2020 年 3 月至 2023 年 5 月期间的全球紧急卫生事件,迄今尚无有效药物。COVID-19疫苗以及其他预防措施,如洗手、消毒、社会隔离等,是在全球范围内减少该疾病负担的唯一方法。本研究旨在确定在政府医学院附属医院住院的 COVID-19 患者中接种 COVID-19 疫苗与疾病严重程度之间的关系。研究方法这项横断面研究纳入了 2021 年 3 月至 2021 年 12 月期间在一家三甲医院住院的 983 名 COVID-19 患者。从病例表中收集第二手数据,并通过电话和 COWIN 应用程序收集患者的疫苗接种详情。研究人员进行了卡方检验和二元逻辑回归,并估算了P值和几率比率。结果92.9%的研究参与者未接种疫苗,2.7%完全接种,4.3%部分接种。在完全接种疫苗的患者中,11.1%出现呼吸困难,0%入住ICU,3.7%死亡,20%在肺部CT中发现COVID肺炎,9%淋巴细胞水平较低,在统计学上显著低于部分接种疫苗的患者(分别为39.5%、41.9%、7%、18.6%、59.3%、65.1%、76.9%)和未接种疫苗的患者(分别为31.1%、27.7%、2%、4.6%、48.2%、45.2%、68.4%)。结论接种两剂疫苗可有效预防严重形式的疾病。部分接种者受影响更大,这可能是由于他们获得的免疫力不足,以及接种疫苗后态度粗心,防护行为减少。本研究表明,部分接种对 COVID-19 疾病严重程度的发展没有保护作用。应更加重视社区的全面疫苗接种,教育公众进行全面疫苗接种,并强调接种后的预防措施,以减少 COVID-19 在社区造成的负担。关键词COVID-19;COWIN App;疫苗接种;冠状病毒病
{"title":"COVID-19 vaccination and its influence on the disease severity among the COVID patients in a tertiary care hospital – A cross sectional study","authors":"Meena Ms, Sangumani J, Brahadeesh M, Natrajan A, John J, Jeyaseelan Djw","doi":"10.17727/jmsr.2023/11-54","DOIUrl":"https://doi.org/10.17727/jmsr.2023/11-54","url":null,"abstract":"Introduction: COVID-19 disease was a global health emergency from March 2020 till May 2023 with no effective drug to date. COVID-19 vaccines with other precautious measures like hand washing, disinfection, social distancing etc. were the only ways to decrease the burden of the disease worldwide. The study aimed to determine the association between COVID-19 vaccination and disease severity among COVID-19 patients admitted to a Government Medical College hospital. Methods: This cross sectional study included 983 COVID-19 patients admitted to a tertiary care hospital from March 2021 to December 2021. Secondary data were collected from the case sheets and vaccination details were collected from the patients over the phone and through COWIN App. Chi-square test and binary logistic regression were done and the p value and odds ratio were estimated. Results: 92.9% of study participants were unvaccinated, 2.7% were fully vaccinated, and 4.3% were partially vaccinated. Among fully vaccinated 11.1% had breathlessness, 0% ICU admission, 3.7% died, 20% had COVID pneumonia findings in CT lung, 9% had low lymphocyte levels which were statistically significantly lower than in partially vaccinated (39.5%, 41.9%, 7%, 18.6%, 59.3%, 65.1%, 76.9% respectively) and unvaccinated (31.1%, 27.7%, 2%, 4.6%, 48.2%, 45.2%, 68.4% respectively). Conclusion: Two doses of vaccines provided significant protection from severe forms of the disease. Partially vaccinated were affected more, which may be due to insufficient immunity gained and their careless attitude post-vaccination with decreased shielding behaviour. The present study shows that partial vaccination is not protective against the progression of COVID-19 disease severity. More focus should be made on full vaccination of the community and educating the public about complete vaccination and emphasis on preventive measures even after vaccination must be made to reduce the burden of COVID-19 in the community. Keywords: COVID-19; COWIN App; vaccination; coronavirus disease","PeriodicalId":32890,"journal":{"name":"Journal of Medical and Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139324848","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Detection of carbapenemase production in gram negative bacilli in medical and surgical intensive care unit patients in a tertiary care hospital 检测一家三级医院内科和外科重症监护室病人体内革兰氏阴性杆菌的碳青霉烯酶产生情况
Pub Date : 2023-10-02 DOI: 10.17727/jmsr.2023/11-56
Kadel S, Bilolikar Ak, Eswaran Sp, Krishnaveni M, Fatima R, Sahu S
Background: Carbapenem-resistant Enterobacterales (CRE) are an urgent global public health problem. CRE infections are associated with high mortality and have limited available effective treatment. Carbapenemase enzymes are encoded by genes on mobile genetic elements, such as plasmids, which are highly transmissible between organisms and increase the potential spread of resistance. The study aim was to detect carbapenemase production in Gram negative bacilli by phenotypic (CarbaNP and mCIM only or in conjunction with eCIM) and genotypic (Xpert Carba-R) methods. Material and methods: The various clinical samples were processed as per standard recommended procedures. Identification and antibiotic susceptibility test were done by using GN cards and AST N280 & AST N281 cards of Vitek 2 Compact (bioMérieux) respectively. Phenotypic (CarbaNP and mCIM only or in conjunction with eCIM) and genotypic (Xpert Carba-R) methods were used for detection of carbapenemases. Result: 144 carbapenem-resistant Gram-negative bacilli isolated from various ICUs includes Klebsiella pneumoniae 52.7% (76/144) followed by Escherichia coli 18.05% (26/144) and 15.9% (23/144) Acinetobacter baumannii. Phenotypic test (CarbaNP and mCIM and or in conjunction with eCIM) showed sensitivity of 90%, 100% and 93.75% respectively. Genotypic test of 40 isolates showed predominant expression of NDM in 82.5% (33/40) isolates followed by OXA-48 in 40% (16/40). Conclusion: The study showed mCIM as the most useful diagnostic test with less economic burden to the patients. There is an urgent need for more sensitive, rapid, highly precise and accurate genotypic test which is less expensive and less labor-intensive. Keywords: carbapenem resistant; Enterobacterales; mCIM; eCIM; Xpert Carba-R
背景:耐碳青霉烯类肠杆菌(CRE)是一个紧迫的全球公共卫生问题。CRE 感染的死亡率很高,而且有效治疗手段有限。碳青霉烯酶由质粒等移动遗传因子上的基因编码,质粒等移动遗传因子在生物体之间高度传播,增加了耐药性传播的可能性。本研究旨在通过表型(仅 CarbaNP 和 mCIM 或结合 eCIM)和基因型(Xpert Carba-R)方法检测革兰氏阴性杆菌中碳青霉烯酶的产生。材料和方法按照推荐的标准程序处理各种临床样本。分别使用 Vitek 2 Compact(生物梅里埃公司)的 GN 卡、AST N280 卡和 AST N281 卡进行鉴定和抗生素药敏试验。表型(仅 CarbaNP 和 mCIM,或与 eCIM 结合使用)和基因型(Xpert Carba-R)方法用于检测碳青霉烯酶。结果:从不同重症监护病房分离出的 144 株耐碳青霉烯类革兰氏阴性杆菌中,肺炎克雷伯菌占 52.7%(76/144),其次是大肠埃希菌 18.05%(26/144)和鲍曼不动杆菌 15.9%(23/144)。表型检测(CarbaNP 和 mCIM 以及或结合 eCIM)的灵敏度分别为 90%、100% 和 93.75%。对 40 个分离株进行的基因型检测显示,82.5%(33/40)的分离株主要表达 NDM,其次是 40%(16/40)的分离株表达 OXA-48。结论研究表明,mCIM 是最有用的诊断测试,对患者造成的经济负担较轻。目前急需更灵敏、快速、高精度和准确的基因分型检验,且成本更低,劳动强度更小。关键词:耐碳青霉烯类;肠杆菌;mCIM;eCIM;Xpert Carba-R
{"title":"Detection of carbapenemase production in gram negative bacilli in medical and surgical intensive care unit patients in a tertiary care hospital","authors":"Kadel S, Bilolikar Ak, Eswaran Sp, Krishnaveni M, Fatima R, Sahu S","doi":"10.17727/jmsr.2023/11-56","DOIUrl":"https://doi.org/10.17727/jmsr.2023/11-56","url":null,"abstract":"Background: Carbapenem-resistant Enterobacterales (CRE) are an urgent global public health problem. CRE infections are associated with high mortality and have limited available effective treatment. Carbapenemase enzymes are encoded by genes on mobile genetic elements, such as plasmids, which are highly transmissible between organisms and increase the potential spread of resistance. The study aim was to detect carbapenemase production in Gram negative bacilli by phenotypic (CarbaNP and mCIM only or in conjunction with eCIM) and genotypic (Xpert Carba-R) methods. Material and methods: The various clinical samples were processed as per standard recommended procedures. Identification and antibiotic susceptibility test were done by using GN cards and AST N280 & AST N281 cards of Vitek 2 Compact (bioMérieux) respectively. Phenotypic (CarbaNP and mCIM only or in conjunction with eCIM) and genotypic (Xpert Carba-R) methods were used for detection of carbapenemases. Result: 144 carbapenem-resistant Gram-negative bacilli isolated from various ICUs includes Klebsiella pneumoniae 52.7% (76/144) followed by Escherichia coli 18.05% (26/144) and 15.9% (23/144) Acinetobacter baumannii. Phenotypic test (CarbaNP and mCIM and or in conjunction with eCIM) showed sensitivity of 90%, 100% and 93.75% respectively. Genotypic test of 40 isolates showed predominant expression of NDM in 82.5% (33/40) isolates followed by OXA-48 in 40% (16/40). Conclusion: The study showed mCIM as the most useful diagnostic test with less economic burden to the patients. There is an urgent need for more sensitive, rapid, highly precise and accurate genotypic test which is less expensive and less labor-intensive. Keywords: carbapenem resistant; Enterobacterales; mCIM; eCIM; Xpert Carba-R","PeriodicalId":32890,"journal":{"name":"Journal of Medical and Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139324858","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Effects of long term antiseizure medications on atherosclerosis 长期抗癫痫药物对动脉粥样硬化的影响
Pub Date : 2023-10-02 DOI: 10.17727/jmsr.2023/11-60
Babu Bs, Varghese Cp, Gilvaz Pc
Long-term therapy with antiseizure medications (ASMs) has been associated with metabolic consequences that lead to an increase in the risk of atherosclerosis in patients with epilepsy. This study was conducted to assess the effects of ASMs on vascular risk factors namely, serum Lipid profile and C-reactive protein (CRP) in epileptic patients and to assess the correlation between the duration of the ASMs, and carotid intima media thickness (IMT). Forty three adult patient participants who were receiving ASM monotherapy for more than 2 years and 43 control patients were enrolled in this study. All participants received measurement of common carotid artery (CCA) and IMT by B-mode ultrasonography to assess the extent of atherosclerosis. Other measurements included body mass index (BMI), serum lipid profile and CRP. The correlation between duration of ASM and average carotid IMT was calculated by using the Pearson's correlation coefficient method. The majority of subjects on phenytoin 8 (66.7%) were positive for CRP. There was an equal proportion of patients on carbamazepine who were equally positive 5(50%) and negative 5(50%) for CRP. There was a statistically significant association between phenytoin consumption and CRP positivity. There was positive correlation between duration of phenytoin consumption and average IMT. There was a strong positive correlation between duration of phenobarbitone consumption and average IMT and was statistically significant. Our results also suggest that long-term use of ASMs with prominent effects on the enzyme system, including Carbamazepine, phenytoin, sodium valproate or phenobarbitone may contribute to the progression of atherosclerosis in patients with epilepsy. Keywords: epilepsy; ASMs; IMT; CRP; phenytoin; carbamazepine; sodium valproate; phenobarbitone
抗癫痫药物(ASM)的长期治疗与代谢后果有关,代谢后果会导致癫痫患者动脉粥样硬化的风险增加。本研究旨在评估抗癫痫药物对血管风险因素(即癫痫患者的血清脂质和 C 反应蛋白 (CRP))的影响,并评估抗癫痫药物持续时间与颈动脉内膜厚度 (IMT) 之间的相关性。本研究共招募了 43 名接受 ASM 单一疗法超过 2 年的成年患者和 43 名对照组患者。所有参与者都接受了颈总动脉(CCA)和B型超声波内膜厚度(IMT)的测量,以评估动脉粥样硬化的程度。其他测量包括体重指数(BMI)、血清脂质概况和 CRP。采用皮尔逊相关系数法计算了ASM持续时间与平均颈动脉内径之间的相关性。大多数服用苯妥英的受试者有 8 例(66.7%)CRP 阳性。服用卡马西平的患者中,有 5 人(50%)呈 CRP 阳性,有 5 人(50%)呈 CRP 阴性,比例相当。服用苯妥英与 CRP 阳性之间有统计学意义。服用苯妥英钠的时间与平均内径之间呈正相关。服用苯巴比妥的时间与平均 IMT 之间存在很强的正相关性,且在统计学上有意义。我们的研究结果还表明,长期服用对酶系统有显著影响的 ASMs,包括卡马西平、苯妥英、丙戊酸钠或苯巴比妥,可能会导致癫痫患者动脉粥样硬化的进展。关键词:癫痫;ASMs;IMT;CRP;苯妥英;卡马西平;丙戊酸钠;苯巴比妥
{"title":"Effects of long term antiseizure medications on atherosclerosis","authors":"Babu Bs, Varghese Cp, Gilvaz Pc","doi":"10.17727/jmsr.2023/11-60","DOIUrl":"https://doi.org/10.17727/jmsr.2023/11-60","url":null,"abstract":"Long-term therapy with antiseizure medications (ASMs) has been associated with metabolic consequences that lead to an increase in the risk of atherosclerosis in patients with epilepsy. This study was conducted to assess the effects of ASMs on vascular risk factors namely, serum Lipid profile and C-reactive protein (CRP) in epileptic patients and to assess the correlation between the duration of the ASMs, and carotid intima media thickness (IMT). Forty three adult patient participants who were receiving ASM monotherapy for more than 2 years and 43 control patients were enrolled in this study. All participants received measurement of common carotid artery (CCA) and IMT by B-mode ultrasonography to assess the extent of atherosclerosis. Other measurements included body mass index (BMI), serum lipid profile and CRP. The correlation between duration of ASM and average carotid IMT was calculated by using the Pearson's correlation coefficient method. The majority of subjects on phenytoin 8 (66.7%) were positive for CRP. There was an equal proportion of patients on carbamazepine who were equally positive 5(50%) and negative 5(50%) for CRP. There was a statistically significant association between phenytoin consumption and CRP positivity. There was positive correlation between duration of phenytoin consumption and average IMT. There was a strong positive correlation between duration of phenobarbitone consumption and average IMT and was statistically significant. Our results also suggest that long-term use of ASMs with prominent effects on the enzyme system, including Carbamazepine, phenytoin, sodium valproate or phenobarbitone may contribute to the progression of atherosclerosis in patients with epilepsy. Keywords: epilepsy; ASMs; IMT; CRP; phenytoin; carbamazepine; sodium valproate; phenobarbitone","PeriodicalId":32890,"journal":{"name":"Journal of Medical and Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139324864","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Prevalence of preserved ratio impaired spirometry (PRISM) in patients undergoing spirometry in a medical college hospital 在一家医学院附属医院接受肺活量测定的患者中,肺活量测定保留比值受损(PRISM)的发生率
Pub Date : 2023-10-02 DOI: 10.17727/jmsr.2023/11-55
Bansal Kl, Bansal Ss, Bansal S, Sahay S
Background: Many patients come with respiratory symptoms of cough, expectoration and shortness of breath. They also exhibit history of risk factors like smoking etc. but on spirometry they do not meet spirometric criteria of chronic obstructive pulmonary disease (COPD). GOLD 2023 updates have considered such patients in the category of pre-COPD and preserved ratio impaired spirometry (PRISm) and advised to treat and follow these patients and try to prevent them from progressing to COPD. With this objective we tried to look for PRISm and its characteristics in our area. Material and methods: We analyzed the spirometric pattern of all the patients who underwent spirometry in our institution (GS Medical College & Hospital, Pilkhuwa) from January 2022 to December 2022. After applying inclusion and exclusion criteria, the patients were divided into three groups: (I) Normal Group: Patients having post bronchodilator FEV1/FVC ratio ≥ 0.7 and normal FEV1 and FVC. (II) PRISm Group: Patients having post bronchodilator FEV1/FVC ratio ≥ 0.7 but decreased FEV1 (< 80 %) and / or FVC (< 80 %). (III) Unrevealed COPD Group: Patients having post bronchodilator FEV1/FVC ratio < 0.7 irrespective of FEV1 and FVC. Data observed was compared among various groups and analyzed for various parameters. Results: A total of 986 patients underwent spirometry between 1st January 2022 and 31st December 2022. Of this, 302 patients were not considered for study because of exclusion criteria. 684 patients were considered for the study, of whom 261 (38.16%) had normal spirometry, 207 (30.26%) were in the PRISm group and 216 (31.58%) were found to have unrevealed COPD. Conclusion: Occurrence of PRISm is quite high (30.26%) in patients undergoing spirometry for various reasons in our area. Higher age and higher BMI may have contributed to the observations. Additionally, a considerable number of patients (31.58%) were found to have unrevealed COPD. Another finding is that smoking history is seen in more than 70% of male subjects in both PRISm and unrevealed COPD groups. However, the results need confirmation in more studies from different geographical areas. Keywords: spirometry; PRISm; COPD; pulmonary disease
背景:许多患者会出现咳嗽、咳痰和气短等呼吸道症状。他们也有吸烟等危险因素的病史,但肺活量测定结果却不符合慢性阻塞性肺病(COPD)的肺活量测定标准。GOLD 2023 更新版将这类患者归入慢性阻塞性肺疾病前期和肺活量保留比值受损(PRISm)类别,并建议对这些患者进行治疗和随访,尽量避免其发展为慢性阻塞性肺疾病。为此,我们试图在本地区寻找 PRISm 及其特征。材料和方法我们分析了 2022 年 1 月至 2022 年 12 月期间在我院(皮尔库瓦 GS 医学院和医院)接受肺活量测定的所有患者的肺活量模式。在应用纳入和排除标准后,患者被分为三组:(I)正常组:支气管扩张剂后 FEV1/FVC 比率≥ 0.7 且 FEV1 和 FVC 正常的患者。(II) PRISm 组:支气管扩张剂后 FEV1/FVC 比率≥ 0.7 但 FEV1(< 80 %)和/或 FVC(< 80 %)下降的患者。(III) 未揭示慢性阻塞性肺病组:支气管扩张剂后 FEV1/FVC 比值< 0.7 的患者,无论 FEV1 和 FVC 如何。对各组之间观察到的数据进行比较,并对各种参数进行分析。结果2022 年 1 月 1 日至 2022 年 12 月 31 日期间,共有 986 名患者接受了肺活量测定。其中,302 名患者因排除标准而未被考虑纳入研究。研究考虑了 684 名患者,其中 261 人(38.16%)肺活量正常,207 人(30.26%)属于 PRISm 组,216 人(31.58%)被发现患有未揭示的慢性阻塞性肺病。结论在本地区因各种原因接受肺活量测定的患者中,PRISm 的发生率相当高(30.26%)。较高的年龄和较高的体重指数可能是造成这一观察结果的原因。此外,相当多的患者(31.58%)被发现患有未揭示的慢性阻塞性肺病。另一项发现是,在 PRISm 组和未显示慢性阻塞性肺病组中,70% 以上的男性受试者有吸烟史。然而,这些结果还需要更多来自不同地区的研究加以证实。关键词:肺活量;PRISm;慢性阻塞性肺病;肺病
{"title":"Prevalence of preserved ratio impaired spirometry (PRISM) in patients undergoing spirometry in a medical college hospital","authors":"Bansal Kl, Bansal Ss, Bansal S, Sahay S","doi":"10.17727/jmsr.2023/11-55","DOIUrl":"https://doi.org/10.17727/jmsr.2023/11-55","url":null,"abstract":"Background: Many patients come with respiratory symptoms of cough, expectoration and shortness of breath. They also exhibit history of risk factors like smoking etc. but on spirometry they do not meet spirometric criteria of chronic obstructive pulmonary disease (COPD). GOLD 2023 updates have considered such patients in the category of pre-COPD and preserved ratio impaired spirometry (PRISm) and advised to treat and follow these patients and try to prevent them from progressing to COPD. With this objective we tried to look for PRISm and its characteristics in our area. Material and methods: We analyzed the spirometric pattern of all the patients who underwent spirometry in our institution (GS Medical College & Hospital, Pilkhuwa) from January 2022 to December 2022. After applying inclusion and exclusion criteria, the patients were divided into three groups: (I) Normal Group: Patients having post bronchodilator FEV1/FVC ratio ≥ 0.7 and normal FEV1 and FVC. (II) PRISm Group: Patients having post bronchodilator FEV1/FVC ratio ≥ 0.7 but decreased FEV1 (< 80 %) and / or FVC (< 80 %). (III) Unrevealed COPD Group: Patients having post bronchodilator FEV1/FVC ratio < 0.7 irrespective of FEV1 and FVC. Data observed was compared among various groups and analyzed for various parameters. Results: A total of 986 patients underwent spirometry between 1st January 2022 and 31st December 2022. Of this, 302 patients were not considered for study because of exclusion criteria. 684 patients were considered for the study, of whom 261 (38.16%) had normal spirometry, 207 (30.26%) were in the PRISm group and 216 (31.58%) were found to have unrevealed COPD. Conclusion: Occurrence of PRISm is quite high (30.26%) in patients undergoing spirometry for various reasons in our area. Higher age and higher BMI may have contributed to the observations. Additionally, a considerable number of patients (31.58%) were found to have unrevealed COPD. Another finding is that smoking history is seen in more than 70% of male subjects in both PRISm and unrevealed COPD groups. However, the results need confirmation in more studies from different geographical areas. Keywords: spirometry; PRISm; COPD; pulmonary disease","PeriodicalId":32890,"journal":{"name":"Journal of Medical and Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139324439","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Clinico-radiological study of the pancreatic tail in relation to the splenic hilum 胰腺尾部与脾门关系的临床放射学研究
Pub Date : 2023-10-02 DOI: 10.17727/jmsr.2023/11-61
Inbasekaran A, Murugesan Sd, Rajendran K, Gnanasigamani S, Urabinahatti Ka, Hanumantha Rkn, Kanagarathinam Ss, Umesh Rn, Thangasamy S, Satyanesan J
Introduction: Splenectomy is one of the most commonly performed surgical procedures worldwide. The splenic hilum is closely related to adjacent organs like the tail of the pancreas, stomach, splenic flexure of colon, and left kidney. One of the morbid complications of splenectomy is injury to the tail of pancreas. The objective of this study was to assess the anatomical details of the pancreatic tail with respect to the splenic hilum by assessing patient’s abdominal computed tomography (CT) imaging. Methods: A total of 150 patients’ abdominal CT imaging was taken for evaluation in this study. The distance between the pancreatic tail and the splenic hilum was measured. The level of location of the pancreatic tail in relation to the splenic hilum was also noted for each patient. Results: The pancreatic tail was inferior to the level of the splenic hilum in 59.3 percent (n =89) of the patients, superior to the level of the splenic hilum in 2.0 percent (n =3) of the patients, and at the level of the hilum in 38.7 percent (n = 58) of the patients. The mean distance from the pancreatic tail to the splenic hilum was 13.1 ± 5.2 mm. Conclusion: Abdominal CT imaging will provide a road map regarding the location of the pancreatic tail and the distance between the pancreatic tail and the splenic hilum. With the preoperative CT imaging details and efficient surgical dissection as close as possible to the splenic hilum, the potential injury to the pancreatic tail can be prevented. Keywords: splenectomy; pancreatic tail injury; splenic hilum; pancreatic fistula
简介脾切除术是全球最常见的外科手术之一。脾门与胰尾、胃、结肠脾曲和左肾等邻近器官密切相关。脾切除术的发病并发症之一是胰腺尾部损伤。本研究旨在通过评估患者的腹部计算机断层扫描(CT)成像,评估胰腺尾部相对于脾门的解剖细节。研究方法本研究共对 150 名患者的腹部 CT 成像进行了评估。测量胰腺尾部与脾门之间的距离。还记录了每位患者的胰尾与脾门的位置关系。结果:59.3%(n=89)的患者胰尾低于脾门水平,2.0%(n=3)的患者胰尾高于脾门水平,38.7%(n=58)的患者胰尾位于脾门水平。胰尾到脾门的平均距离为 13.1 ± 5.2 毫米。结论腹部 CT 成像可提供有关胰尾位置和胰尾与脾门之间距离的路线图。通过术前 CT 成像细节和尽可能靠近脾门的有效手术解剖,可以避免胰尾可能受到的损伤。关键词:脾切除术;胰尾损伤;脾门;胰瘘
{"title":"Clinico-radiological study of the pancreatic tail in relation to the splenic hilum","authors":"Inbasekaran A, Murugesan Sd, Rajendran K, Gnanasigamani S, Urabinahatti Ka, Hanumantha Rkn, Kanagarathinam Ss, Umesh Rn, Thangasamy S, Satyanesan J","doi":"10.17727/jmsr.2023/11-61","DOIUrl":"https://doi.org/10.17727/jmsr.2023/11-61","url":null,"abstract":"Introduction: Splenectomy is one of the most commonly performed surgical procedures worldwide. The splenic hilum is closely related to adjacent organs like the tail of the pancreas, stomach, splenic flexure of colon, and left kidney. One of the morbid complications of splenectomy is injury to the tail of pancreas. The objective of this study was to assess the anatomical details of the pancreatic tail with respect to the splenic hilum by assessing patient’s abdominal computed tomography (CT) imaging. Methods: A total of 150 patients’ abdominal CT imaging was taken for evaluation in this study. The distance between the pancreatic tail and the splenic hilum was measured. The level of location of the pancreatic tail in relation to the splenic hilum was also noted for each patient. Results: The pancreatic tail was inferior to the level of the splenic hilum in 59.3 percent (n =89) of the patients, superior to the level of the splenic hilum in 2.0 percent (n =3) of the patients, and at the level of the hilum in 38.7 percent (n = 58) of the patients. The mean distance from the pancreatic tail to the splenic hilum was 13.1 ± 5.2 mm. Conclusion: Abdominal CT imaging will provide a road map regarding the location of the pancreatic tail and the distance between the pancreatic tail and the splenic hilum. With the preoperative CT imaging details and efficient surgical dissection as close as possible to the splenic hilum, the potential injury to the pancreatic tail can be prevented. Keywords: splenectomy; pancreatic tail injury; splenic hilum; pancreatic fistula","PeriodicalId":32890,"journal":{"name":"Journal of Medical and Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139324522","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Spectrum of lymph node lesions as per recent Sydney system of lymph node classification 根据最新的悉尼淋巴结分类系统划分的淋巴结病变范围
Pub Date : 2023-10-02 DOI: 10.17727/jmsr.2023/11-52
Verma S, Sinha R, Jaiswal Cp
Background: Lymphadenopathy may be an incidental finding and/or primary or secondary manifestation of underlying diseases which may be neoplastic or non-neoplastic. The aim of the current study was to evaluate the spectrum of lymph node lesions according to the Sydney system in our setting and to assess the risk of malignancy in each category. Methods: The present study was carried out in the Department of Pathology, Nalanda Medical College and Hospital, Patna (Bihar) retrospectively during a one-year period from November 2020 to October 2021. 332 FNACs were performed on patients and the ROM (Risk of Malignancy) was assessed for each diagnostic category. Results: In the present study, 11 cases were categorized as L1, inadequate/non-diagnostic; 291 cases as L2,benign; 06 cases as L3, AUS/ALUS; 03 as L4, Suspicious for malignancy, and finally 21 cases were categorized as L5, Malignant. The ROM was 1.28% in L2, 50% in L3, and 100% in L4,L5. ROM for L1 category could not be assessed. Conclusion: The universal implementation of the Sydney system of reporting lymph node cytopathology can improve the diagnostic accuracy which will not only instill confidence in the pathologists but also help the clinicians to adopt better management strategies. Keywords: granulomatous; lymphadenitis; lymphoma; metastases; malignancy
背景:淋巴结病可能是偶然发现和/或潜在疾病的原发或继发表现,这些疾病可能是肿瘤性的,也可能是非肿瘤性的。本研究的目的是根据悉尼系统评估本院淋巴结病变的范围,并评估各类淋巴结病变的恶性风险。研究方法本研究在巴特那(比哈尔邦)纳兰达医学院和医院病理科进行,自 2020 年 11 月至 2021 年 10 月,为期一年。对患者进行了 332 例 FNAC,并对每个诊断类别的 ROM(恶性肿瘤风险)进行了评估。结果:在本研究中,11 例被归类为 L1,诊断不充分/非诊断;291 例被归类为 L2,良性;06 例被归类为 L3,AUS/ALUS;03 例被归类为 L4,可疑恶性,最后 21 例被归类为 L5,恶性。L2的ROM为1.28%,L3为50%,L4和L5为100%。L1类的ROM无法评估。结论普遍采用悉尼系统报告淋巴结细胞病理学可提高诊断准确性,这不仅会给病理学家带来信心,还有助于临床医生采取更好的管理策略。关键词:肉芽肿;淋巴结炎;淋巴瘤;转移;恶性肿瘤
{"title":"Spectrum of lymph node lesions as per recent Sydney system of lymph node classification","authors":"Verma S, Sinha R, Jaiswal Cp","doi":"10.17727/jmsr.2023/11-52","DOIUrl":"https://doi.org/10.17727/jmsr.2023/11-52","url":null,"abstract":"Background: Lymphadenopathy may be an incidental finding and/or primary or secondary manifestation of underlying diseases which may be neoplastic or non-neoplastic. The aim of the current study was to evaluate the spectrum of lymph node lesions according to the Sydney system in our setting and to assess the risk of malignancy in each category. Methods: The present study was carried out in the Department of Pathology, Nalanda Medical College and Hospital, Patna (Bihar) retrospectively during a one-year period from November 2020 to October 2021. 332 FNACs were performed on patients and the ROM (Risk of Malignancy) was assessed for each diagnostic category. Results: In the present study, 11 cases were categorized as L1, inadequate/non-diagnostic; 291 cases as L2,benign; 06 cases as L3, AUS/ALUS; 03 as L4, Suspicious for malignancy, and finally 21 cases were categorized as L5, Malignant. The ROM was 1.28% in L2, 50% in L3, and 100% in L4,L5. ROM for L1 category could not be assessed. Conclusion: The universal implementation of the Sydney system of reporting lymph node cytopathology can improve the diagnostic accuracy which will not only instill confidence in the pathologists but also help the clinicians to adopt better management strategies. Keywords: granulomatous; lymphadenitis; lymphoma; metastases; malignancy","PeriodicalId":32890,"journal":{"name":"Journal of Medical and Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139324618","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Demystifying the three different types of COVID-19 associated multisystem inflammatory syndrome in children: Experience from a tertiary care hospital 解密与 COVID-19 相关的儿童多系统炎症综合征的三种不同类型:一家三级医院的经验
Pub Date : 2023-10-02 DOI: 10.17727/jmsr.2023/11-62
Nerella S, Basu S, Pati S, Biswas T, Majumdar I, Datta S
Background: Following the coronavirus disease-2019 (COVID-19) pandemic, a new entity emerged termed as multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 (MISC) by the World Health Organization (WHO). Infection with COVID-19 triggers the formation of antibodies to viral surface epitopes. It is believed that low titer non-neutralizing antibodies may accentuate virus-triggered immune responses. The study aimed to describe the various clinical presenting features, deranged laboratory parameters, echocardiographic findings, and immediate outcome and to categorize into 3 types of MISC and find any difference among the 3 types. Methodology: Children 29-days old to 12-years old who clinically satisfied the published WHO’s case definition for MISC were included in the study. All children were subjected to serological testing for total immunoglobulin to viral spike glycoprotein, relevant blood investigations, and echocardiography. Results: Out of 50 cases, we had 24(48%) cases of MISC without shock, 12(24%) cases of Kawasaki disease-like phenotype, and 14(28%) cases of MISC with shock. Fever (96%) and respiratory complaints (64%) predominate followed by gastrointestinal (45%) and red eye (32%). The inflammatory markers were notably elevated- the median CRP was 39.6mg/L, median ESR was 70mm 1sthr, median procalcitonin was 8.2 ng/ml. There is a significant drop in inflammatory markers post-treatment (p=0.019, p=0.000, p=0.016 respectively for CRP, ESR and procalcitonin). Abnormal echocardiographic findings were seen in 46% of cases in terms of decreased ejection fraction and coronary artery aneurysms (CAA). There were 7 deaths (14%), and 42(84%) patients were successfully discharged. Conclusion: Following the COVID-19 pandemic, MISC has emerged with its characteristic clinical pattern which needs early identification and prompt treatment to prevent mortality and morbidity. Keywords: MISC; non-COVID; Eastern India; Kawasaki disease; PIMS-TS; IVIG; immunity
背景:冠状病毒病-2019(COVID-19)大流行之后,出现了一种新的实体,世界卫生组织(WHO)称之为与 COVID-19 (MISC)时间相关的儿童和青少年多系统炎症综合征。感染 COVID-19 会引发病毒表面表位抗体的形成。人们认为,低滴度非中和抗体可能会加剧病毒引发的免疫反应。本研究旨在描述各种临床表现特征、实验室指标异常、超声心动图检查结果和即时结果,并将 MISC 分为 3 种类型,找出 3 种类型之间的差异。研究方法研究对象包括出生 29 天至 12 岁的儿童,这些儿童在临床上符合世界卫生组织公布的 MISC 病例定义。对所有儿童进行病毒性尖峰糖蛋白总免疫球蛋白血清学检测、相关血液检查和超声心动图检查。研究结果在50例病例中,24例(48%)为无休克的MISC,12例(24%)为川崎病样表型,14例(28%)为伴有休克的MISC。患者以发热(96%)和呼吸道症状(64%)为主,其次是胃肠道症状(45%)和红眼病(32%)。炎症指标明显升高--CRP 中位数为 39.6mg/L,ESR 中位数为 70mm 1sthr,降钙素原中位数为 8.2 ng/ml。治疗后,炎症指标明显下降(CRP、ESR 和降钙素分别为 p=0.019、p=0.000、p=0.016)。46%的病例出现射血分数下降和冠状动脉瘤(CAA)等异常超声心动图检查结果。有 7 例死亡(14%),42 例(84%)患者顺利出院。结论COVID-19 大流行后,MISC 出现了其特有的临床模式,需要早期识别和及时治疗,以防止死亡和发病。关键词:MISC;非 COVIDMISC;非 COVID;印度东部;川崎病;PIMS-TS;IVIG;免疫力
{"title":"Demystifying the three different types of COVID-19 associated multisystem inflammatory syndrome in children: Experience from a tertiary care hospital","authors":"Nerella S, Basu S, Pati S, Biswas T, Majumdar I, Datta S","doi":"10.17727/jmsr.2023/11-62","DOIUrl":"https://doi.org/10.17727/jmsr.2023/11-62","url":null,"abstract":"Background: Following the coronavirus disease-2019 (COVID-19) pandemic, a new entity emerged termed as multisystem inflammatory syndrome in children and adolescents temporally related to COVID-19 (MISC) by the World Health Organization (WHO). Infection with COVID-19 triggers the formation of antibodies to viral surface epitopes. It is believed that low titer non-neutralizing antibodies may accentuate virus-triggered immune responses. The study aimed to describe the various clinical presenting features, deranged laboratory parameters, echocardiographic findings, and immediate outcome and to categorize into 3 types of MISC and find any difference among the 3 types. Methodology: Children 29-days old to 12-years old who clinically satisfied the published WHO’s case definition for MISC were included in the study. All children were subjected to serological testing for total immunoglobulin to viral spike glycoprotein, relevant blood investigations, and echocardiography. Results: Out of 50 cases, we had 24(48%) cases of MISC without shock, 12(24%) cases of Kawasaki disease-like phenotype, and 14(28%) cases of MISC with shock. Fever (96%) and respiratory complaints (64%) predominate followed by gastrointestinal (45%) and red eye (32%). The inflammatory markers were notably elevated- the median CRP was 39.6mg/L, median ESR was 70mm 1sthr, median procalcitonin was 8.2 ng/ml. There is a significant drop in inflammatory markers post-treatment (p=0.019, p=0.000, p=0.016 respectively for CRP, ESR and procalcitonin). Abnormal echocardiographic findings were seen in 46% of cases in terms of decreased ejection fraction and coronary artery aneurysms (CAA). There were 7 deaths (14%), and 42(84%) patients were successfully discharged. Conclusion: Following the COVID-19 pandemic, MISC has emerged with its characteristic clinical pattern which needs early identification and prompt treatment to prevent mortality and morbidity. Keywords: MISC; non-COVID; Eastern India; Kawasaki disease; PIMS-TS; IVIG; immunity","PeriodicalId":32890,"journal":{"name":"Journal of Medical and Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139324261","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
Tumor budding in colorectal adenocarcinoma using cytokeratin 20 immunostaining 利用细胞角蛋白 20 免疫染色法检测结直肠腺癌的肿瘤出芽情况
Pub Date : 2023-10-02 DOI: 10.17727/jmsr.2023/11-53
C. N, Sundar Rns, Kumar Hks, Nataraju G, Esaivani Kb
Introduction: Colorectal cancer is the third most common cancer worldwide and second most common fatal cancer. Tumor budding is an emerging prognostic indicator in cancers. Though tumor budding can be assessed using Hematoxylin and Eosin stain, sometimes peritumoral inflammation and reactive stromal fibrosis obscures the tumor buds. The present study aimed to assess tumor budding using cytokeratin 20 immunohistochemistry in colorectal cancers. Methods: This is a cross sectional study which included 30 cases of colorectal carcinomas. cytokeratin 20 stained slides of colorectal carcinoma were assesed for tumor budding using International Tumor Budding Consensus Conference (ITBCC) 2016 consensus criteria and compared with AJCC cancer stage. Results: Demographic analysis showed peak incidence of colorectal cancer in the age group of 55-64 years (33.3%) and male: female ratio of 1.14:1. Majority of the tumors with score 1(23.3%) showed stage I. While tumors with score 2 had similar incidence of stage I (16.6%) and II (16.6%) and lesser incidence of stage III (3.33%). Most of the tumors with score 3 tumor budding had stage III tumors (26.67%). The p value is < 0.0001, which is statistically significant. Tumor budding signifies the biological and molecular phenomenon of epithelial-mesenchymal transition in the tumor microenvironment. Loss of E-cadherin, alterations in transcription factors including SNAIL, ZEB, TWIST etc and switching of CMS2 to CMS4 are some of the recorded molecular profiles responsible for tumor budding. Conclusion: This study concludes that the tumor stage increases with tumor budding and thus is a reliable marker in predicting the prognosis. This study also states that immunohistochemical study gives objective scoring of tumor buds in colorectal cancers. Keywords: tumor budding; colorectal cancer; cytokeratin 20; prognostic marker
导言结直肠癌是全球第三大常见癌症,也是第二大致命癌症。肿瘤萌芽是癌症预后的一个新指标。虽然可以用苏木精和伊红染色法评估肿瘤萌芽,但有时瘤周炎症和反应性基质纤维化会掩盖肿瘤萌芽。本研究旨在利用细胞角蛋白20免疫组化技术评估结直肠癌中的肿瘤萌芽。研究方法采用国际肿瘤萌芽共识会议(ITBCC)2016年共识标准对细胞角蛋白20染色的结直肠癌切片进行肿瘤萌芽评估,并与AJCC癌症分期进行比较。结果人口统计学分析显示,结直肠癌的发病高峰在55-64岁年龄组(33.3%),男女比例为1.14:1。大多数得分 1 的肿瘤(23.3%)为 I 期,得分 2 的肿瘤 I 期(16.6%)和 II 期(16.6%)发病率相似,III 期发病率较低(3.33%)。大部分得分 3 的肿瘤萌芽为 III 期肿瘤(26.67%)。P 值小于 0.0001,具有统计学意义。肿瘤出芽标志着肿瘤微环境中上皮-间质转化的生物学和分子现象。E-cadherin的缺失、转录因子(包括SNAIL、ZEB、TWIST等)的改变以及CMS2向CMS4的转换是导致肿瘤出芽的一些记录在案的分子特征。结论本研究得出结论,肿瘤分期随肿瘤出芽而增加,因此是预测预后的可靠标志物。本研究还指出,免疫组化研究可对结直肠癌中的肿瘤萌芽进行客观评分。关键词:肿瘤萌芽;结直肠癌;细胞角蛋白20;预后标志物
{"title":"Tumor budding in colorectal adenocarcinoma using cytokeratin 20 immunostaining","authors":"C. N, Sundar Rns, Kumar Hks, Nataraju G, Esaivani Kb","doi":"10.17727/jmsr.2023/11-53","DOIUrl":"https://doi.org/10.17727/jmsr.2023/11-53","url":null,"abstract":"Introduction: Colorectal cancer is the third most common cancer worldwide and second most common fatal cancer. Tumor budding is an emerging prognostic indicator in cancers. Though tumor budding can be assessed using Hematoxylin and Eosin stain, sometimes peritumoral inflammation and reactive stromal fibrosis obscures the tumor buds. The present study aimed to assess tumor budding using cytokeratin 20 immunohistochemistry in colorectal cancers. Methods: This is a cross sectional study which included 30 cases of colorectal carcinomas. cytokeratin 20 stained slides of colorectal carcinoma were assesed for tumor budding using International Tumor Budding Consensus Conference (ITBCC) 2016 consensus criteria and compared with AJCC cancer stage. Results: Demographic analysis showed peak incidence of colorectal cancer in the age group of 55-64 years (33.3%) and male: female ratio of 1.14:1. Majority of the tumors with score 1(23.3%) showed stage I. While tumors with score 2 had similar incidence of stage I (16.6%) and II (16.6%) and lesser incidence of stage III (3.33%). Most of the tumors with score 3 tumor budding had stage III tumors (26.67%). The p value is < 0.0001, which is statistically significant. Tumor budding signifies the biological and molecular phenomenon of epithelial-mesenchymal transition in the tumor microenvironment. Loss of E-cadherin, alterations in transcription factors including SNAIL, ZEB, TWIST etc and switching of CMS2 to CMS4 are some of the recorded molecular profiles responsible for tumor budding. Conclusion: This study concludes that the tumor stage increases with tumor budding and thus is a reliable marker in predicting the prognosis. This study also states that immunohistochemical study gives objective scoring of tumor buds in colorectal cancers. Keywords: tumor budding; colorectal cancer; cytokeratin 20; prognostic marker","PeriodicalId":32890,"journal":{"name":"Journal of Medical and Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-10-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"139324714","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
A comparative study to determine clinical and spirometric profile among patients of asthma in different body mass index groups 不同体重指数组哮喘患者的临床和肺活量谱的比较研究
Pub Date : 2023-07-01 DOI: 10.17727/jmsr.2023/11-37
Shreenivasa A, Chaudhary A, Wagganavar PB, Mahmood T, Shukla AD, Acharya KV
Background: Overweight and obesity is the most common co-morbidity and disease modifier of asthma; it has been associated with increased risk of asthma exacerbations, worse respiratory symptoms and poor asthma control. The objective of study was to determine the relation of body mass index (BMI) with the level of asthma control and to study the clinical presentation and spirometric profile of asthma patients from different BMI groups. Materials and methods: The descriptive prospective study done among confirmed asthmatic patients who were attending the Department of Pulmonary Medicine, outpatient department (OPD) and inpatient department (IPD). The study was demographic, clinical and spirometric parameters in asthmatic patients who were on optimal pharmacotherapy among different BMI categories. Results: Total 144 diagnosed asthma patients were included; the overall mean age of the study group was 34.27 ± 11.7 years and the majority of patients 50 (34.72%) were between 18-27 years of age group. Moderate asthma (FEV1 60-79) was observed to be the most common in all BMI groups. The severe asthma (FEV1 <60) was observed with BMI > 30kg/m2 in asthma patients (p=0.27). Conclusions: The poor control of asthma was significantly frequent in the overweight and obese BMI group, regardless of the findings of no differences in spirometry. Our results suggest that obese individuals with asthma show a higher incidence of one-year follow-up hospitalization due to exacerbation symptoms than non-obese individuals.
背景:超重和肥胖是哮喘最常见的合并症和疾病调节剂;它与哮喘恶化的风险增加、呼吸系统症状恶化和哮喘控制不良有关。研究的目的是确定体重指数(BMI)与哮喘控制水平的关系,并研究不同BMI组哮喘患者的临床表现和肺活量谱。材料与方法:对在肺内科、门诊部和住院部就诊的确诊哮喘患者进行描述性前瞻性研究。该研究对不同BMI类别中接受最佳药物治疗的哮喘患者的人口学、临床和肺活量参数进行了研究。结果:共纳入144例确诊哮喘患者;研究组患者总体平均年龄为34.27±11.7岁,18-27岁年龄组占患者总数的34.72%。中度哮喘(FEV1 60-79)在所有BMI组中最为常见。重度哮喘(FEV1 <60)以BMI >哮喘患者30kg/m2 (p=0.27)。结论:超重和肥胖BMI组哮喘控制不良发生率显著升高,尽管肺量测定结果无差异。我们的研究结果表明,肥胖的哮喘患者在一年随访中因症状加重而住院的发生率高于非肥胖者。
{"title":"A comparative study to determine clinical and spirometric profile among patients of asthma in different body mass index groups","authors":"Shreenivasa A, Chaudhary A, Wagganavar PB, Mahmood T, Shukla AD, Acharya KV","doi":"10.17727/jmsr.2023/11-37","DOIUrl":"https://doi.org/10.17727/jmsr.2023/11-37","url":null,"abstract":"Background: Overweight and obesity is the most common co-morbidity and disease modifier of asthma; it has been associated with increased risk of asthma exacerbations, worse respiratory symptoms and poor asthma control. The objective of study was to determine the relation of body mass index (BMI) with the level of asthma control and to study the clinical presentation and spirometric profile of asthma patients from different BMI groups. Materials and methods: The descriptive prospective study done among confirmed asthmatic patients who were attending the Department of Pulmonary Medicine, outpatient department (OPD) and inpatient department (IPD). The study was demographic, clinical and spirometric parameters in asthmatic patients who were on optimal pharmacotherapy among different BMI categories. Results: Total 144 diagnosed asthma patients were included; the overall mean age of the study group was 34.27 ± 11.7 years and the majority of patients 50 (34.72%) were between 18-27 years of age group. Moderate asthma (FEV1 60-79) was observed to be the most common in all BMI groups. The severe asthma (FEV1 <60) was observed with BMI > 30kg/m2 in asthma patients (p=0.27). Conclusions: The poor control of asthma was significantly frequent in the overweight and obese BMI group, regardless of the findings of no differences in spirometry. Our results suggest that obese individuals with asthma show a higher incidence of one-year follow-up hospitalization due to exacerbation symptoms than non-obese individuals.","PeriodicalId":32890,"journal":{"name":"Journal of Medical and Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135812072","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
The significance of ratio between serum triglycerides and HDL cholesterol as a common man’s bio marker of insulin resistance in type 2 diabetes mellitus: A cross sectional comparative study 血清甘油三酯和高密度脂蛋白胆固醇比值作为2型糖尿病胰岛素抵抗的生物标志物的意义:一项横断面比较研究
Pub Date : 2023-07-01 DOI: 10.17727/jmsr.2023/11-39
Krishnamurthy HA, Bhangari VS, Sandesh L
Introduction: Insulin resistance is the most common abnormality associated with obesity, as a major pathophysiological factor in the development and progression of cardiovascular diseases and diabetes mellitus. This study is undertaken to know the significance of ratio of triglycerides (TG) to high-density lipoprotein (HDL) cholesterol as a serum biomarker in assessing the insulin resistance compared to homeostatic model assessment of insulin resistance (HOMA-IR) in type 2 diabetes mellitus (DM) subjects. Materials and methods: This was a cross sectional comparative study done at Mysore Medical College and Research Institute, Mysuru on 180 subjects of type 2 DM from April 2022 to October 2022. The blood sample was subjected for laboratory tests, such as complete blood count (CBC), fasting blood sugar (FBS), post prandial blood sugar (PPBS), HbA1c, lipid profile, ECG, serum insulin level and HOMA-IR, renal function tests (RFT), liver function tests (LFT). The results were tabulated and compared between the HOMA-IR value and triglycerides/HDL cholesterol ratio of type 2 DM subjects. The cut off value of HOMA-IR to assess insulin resistance was 2.50 and triglycerides to HDL ratio was 3.0. Results: The majority of patients i.e. 112(62.22%) had TG/HDL ratio of >3.0 and 116(64.44%) patients had HOMA-IR of >2.5.The patients with uncontrolled type 2 DM had significantly higher TG/HDL ratio [p value 0.01] and HOMA-IR (p value- 0.01). Conclusion: This study concludes that, the ratio of serum triglycerides /HDL cholesterol is a cost effective blood biomarker and it’s correlating significantly with the HOMA-IR and serum fasting insulin levels, while assessing the insulin resistance in type 2 DM subjects.
导读:胰岛素抵抗是最常见的与肥胖相关的异常,是心血管疾病和糖尿病发生发展的主要病理生理因素。本研究旨在了解甘油三酯(TG)与高密度脂蛋白(HDL)胆固醇的比值作为评估2型糖尿病(DM)受试者胰岛素抵抗的血清生物标志物的意义,并与胰岛素抵抗的稳态模型评估(HOMA-IR)进行比较。材料和方法:这是一项横断面比较研究,于2022年4月至2022年10月在迈索尔医学院和迈索尔研究所对180名2型糖尿病患者进行了研究。血样进行实验室检测,如全血细胞计数(CBC)、空腹血糖(FBS)、餐后血糖(PPBS)、糖化血红蛋白(HbA1c)、血脂、心电图、血清胰岛素水平和HOMA-IR、肾功能检查(RFT)、肝功能检查(LFT)。将结果制成表格,比较2型糖尿病患者的HOMA-IR值和甘油三酯/高密度脂蛋白胆固醇比值。HOMA-IR评价胰岛素抵抗的临界值为2.50,甘油三酯与高密度脂蛋白比值为3.0。结果:112例(62.22%)患者TG/HDL比值为3.0,116例(64.44%)患者HOMA-IR值为2.5。未控制的2型糖尿病患者TG/HDL比值(p值0.01)和HOMA-IR (p值- 0.01)均显著升高。结论:血清甘油三酯/高密度脂蛋白胆固醇比值是一种经济有效的血液生物标志物,可与HOMA-IR和血清空腹胰岛素水平显著相关,可用于评估2型糖尿病患者的胰岛素抵抗。
{"title":"The significance of ratio between serum triglycerides and HDL cholesterol as a common man’s bio marker of insulin resistance in type 2 diabetes mellitus: A cross sectional comparative study","authors":"Krishnamurthy HA, Bhangari VS, Sandesh L","doi":"10.17727/jmsr.2023/11-39","DOIUrl":"https://doi.org/10.17727/jmsr.2023/11-39","url":null,"abstract":"Introduction: Insulin resistance is the most common abnormality associated with obesity, as a major pathophysiological factor in the development and progression of cardiovascular diseases and diabetes mellitus. This study is undertaken to know the significance of ratio of triglycerides (TG) to high-density lipoprotein (HDL) cholesterol as a serum biomarker in assessing the insulin resistance compared to homeostatic model assessment of insulin resistance (HOMA-IR) in type 2 diabetes mellitus (DM) subjects. Materials and methods: This was a cross sectional comparative study done at Mysore Medical College and Research Institute, Mysuru on 180 subjects of type 2 DM from April 2022 to October 2022. The blood sample was subjected for laboratory tests, such as complete blood count (CBC), fasting blood sugar (FBS), post prandial blood sugar (PPBS), HbA1c, lipid profile, ECG, serum insulin level and HOMA-IR, renal function tests (RFT), liver function tests (LFT). The results were tabulated and compared between the HOMA-IR value and triglycerides/HDL cholesterol ratio of type 2 DM subjects. The cut off value of HOMA-IR to assess insulin resistance was 2.50 and triglycerides to HDL ratio was 3.0. Results: The majority of patients i.e. 112(62.22%) had TG/HDL ratio of &gt;3.0 and 116(64.44%) patients had HOMA-IR of &gt;2.5.The patients with uncontrolled type 2 DM had significantly higher TG/HDL ratio [p value 0.01] and HOMA-IR (p value- 0.01). Conclusion: This study concludes that, the ratio of serum triglycerides /HDL cholesterol is a cost effective blood biomarker and it’s correlating significantly with the HOMA-IR and serum fasting insulin levels, while assessing the insulin resistance in type 2 DM subjects.","PeriodicalId":32890,"journal":{"name":"Journal of Medical and Scientific Research","volume":null,"pages":null},"PeriodicalIF":0.0,"publicationDate":"2023-07-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"135812445","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 0
期刊
Journal of Medical and Scientific Research
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1